GSA Capital Partners’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $536K | Sell |
|
|||||
|
2024
Q4 | $575K | Sell |
|
|||||
|
2024
Q3 | $444K | Buy |
|
|||||
|
2024
Q2 | $469K | Sell |
|
|||||
|
2024
Q1 | $622K | Sell |
|
|||||
|
2023
Q4 | $969K | Buy |
|
|||||
|
2023
Q3 | $825K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $20K | Sell |
|
|||||
|
2021
Q3 | $339K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $36K | Buy |
|